2025-12-17T15:48:51-06:00 2022-12-31 010523282 Berry Dunn McNeil & Parker LLC 2211 Congress St Portland ME 04102 990 2022-01-01 813327581 Advanced Regenerative Manufacturing Institute Inc ADVA 6036663905 400 Commercial St Manchester NH 03101 Jennifer MacDonald Chief Operating Officer 6036663905 2025-12-17 1 1 Melissa Magoon CPA P01712842 2077752387 2025-12-17 2022 2025-03-06 01:10:19Z X Maureen Toohey 400 Commercial St Manchester NH 03101 30061391 0 X https://www.armiusa.org/ X 2016 NH ARMI's mission is to support, develop, advance and promote the United States bioeconomy. 5 5 64 150 0 0 25317444 28539924 1235171 1511772 8405 9695 0 0 26561020 30061391 13091692 14140651 0 0 3540163 5185046 0 0 0 4920692 8174050 21552547 27499747 5008473 2561644 22637554 28649661 8034241 11484704 14603313 17164957 X ARMI's mission is to support, develop, advance and promote the United States bioeconomy. 0 0 ARMI and its BioFabUSA Institute accomplishes its mission through key activities, such as the following: Collaborates with community, local, State, and Federal stakeholders to advance the U.S bioeconomy and fuel inclusive economic growth, including by creating pathways and access to jobs in the biofabrication industry. Provides wrap-around commercialization services for tissue engineering and enabling technology companies. These efforts de-risk and accelerate translation of impactful technologies to market. Funds technical projects that address many of the common manufacturing challenges faced by companies in the field of tissue engineering. This will allow tissue engineering and enabling technology companies to focus their time and resources on product-specific challenges, moving the entire industry forward more quickly and efficiently. Funds education and workforce development (EWD) projects that address the industry need for trained employees with a broad base of biomanufacturing skills and specific expertise. This pressing need can otherwise constrain the growth of tissue engineering and enabling technology companies. In coordination with organizations in the field of regenerative manufacturing, develops roadmaps of technical and EWD needs for the field. These roadmaps guide the work of organizations in the field of regenerative manufacturing and guide the selection of projects. Hosts, sponsors, and participates in conferences and workshops that convene organizations that support regenerative manufacturing. These events allow for shared learning related to technical, regulatory, workforce, and financial challenges and solutions. Shares information about best practices and innovations in the field via various fora and online resources.NextFab accomplishes is mission through key activities, such as the following: Establish framework for demand-based Advisory Panels to conduct expert seminars and other thought-leadership efforts. Develop commercial advisory and consulting programs designed to accelerate adoption of advanced technologies. Provide shared facilities to accelerate advanced technologies. Performs projects of interest to U.S. Department of Health and Human Services. 0 1 0 1 0 0 0 0 0 1 0 0 1 1 1 0 1 0 0 1 1 0 0 0 0 0 1 0 1 0 0 1 0 0 1 1 0 0 0 0 1 0 0 1 35 0 1 64 1 0 0 0 0 0 0 0 0 0 0 X 5 5 1 0 0 0 1 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 X Thomas Deyak CPA 6036663905 400 Commercial St Manchester NH 03101 X X Dean Kamen Executive Director 5.00 X X 0 0 0 Martine Rothblatt Board Member 1.00 X 0 0 0 John Abele Board Member 1.00 X 0 0 0 Jim Weinstein Board Member 1.00 X 0 0 0 Blake Moret Board Member 1.00 X 0 0 0 Maureen Toohey Deputy Executive Director 25.00 X 0 0 0 James Scott Chief Operating Officer 15.00 X 0 0 0 Brendan Duffy Treasurer 1.00 X 0 0 0 Richard McFarland Chief Regulatory Officer 40.00 X 195289 0 26263 Edward Gordon Chief Operating Officer - BioFab 40.00 X 192727 0 35537 Julie Lenzer Chief Innovation Officer 40.00 X 178100 0 15533 Jeremiah Wille Sr Regulatory Affairs Specialist 40.00 X 160000 0 594 Kelly Morbey Director of Regulatory Affairs &QA 40.00 X 155000 0 11960 881116 0 89887 12 0 1 0 Nexight Group LLC 1100 Wayne Avenue Suite 1100 Silver Spring MD 20910 Consultant - HHS Programs 284332 Stefany Shaheen 77 South Street Portsmouth NH 03801 Consultant 142000 3 27207838 1332086 183408 28539924 Membership Dues 541700 1098702 1098702 Other Program Revenue 541700 221167 221167 Management Fee Revenue 541700 191903 191903 1511772 9695 9695 30061391 1511772 0 9695 12167782 1972869 4364797 92010 395284 332955 45420 1473833 42529 290724 378382 1092552 171791 773924 1772751 44508 Lab Materials & Supplie 2087636 27499747 362019 224206 8079318 9697118 4481342 4452276 352893 398735 14233980 3581111 9272970 10652869 89012 119415 0 3105042 22637554 28649661 7014812 6919240 1019429 1460422 0 3105042 8034241 11484704 X 14603313 17164957 14603313 17164957 22637554 28649661 2561644 0 X 0 1 X 1 1 1 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 5156875 246414 4910461 9077105 3334697 5742408 10652869 Right-of-use Assets 3105042 3105042 Lease Obligations 3105042 3105042 X Part X, Line 2: ARMI, Inc. is a not-for-profit corporation, as described under Section 501(c)(6) of the Internal Revenue Code, exempt from federal and state income taxes on income related to the fulfillment of ARMI, Inc.'s mission. Accordingly, no income tax expense for ARMI, Inc. has been reported in these financial statements. BioIndustries is a taxable entity and files a federal income tax return. Deferred taxes related to BioIndustries are based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect in the years the differences are expected to reverse. Management has evaluated BioIndustries' tax positions and determined that there are no tax positions requiring accounting recognition. Income tax returns filed by BioIndustries are subject to examination by the Internal Revenue Service for a period of three years. While no income tax returns are currently being examined by the Internal Revenue Service, the two previous tax years remain open. No interest or penalties from federal or state tax authorities were recorded in the accompanying consolidated financial statements. 1 Netherlands 0 0 Grant - BioFab USA Cares Act Funded Program (DoD Directed) 1350819 Israel 0 0 Grant - NextFab Bilateral Health Tech Hub Program (HHS-Directed) 622050 0 0 0 0 0 0 1972869 0 1972869 Netherlands BioFab USA CARES Act Funded Program (DoD Directed) 1350819 Wire transfer 0 Israel NextFab Bilateral Health Tech Hub Program (HHS-Directed) 422050 Wire transfer 0 Israel NextFab Bilateral Health Tech Hub Program (HHS-Directed) 200000 Wire transfer 0 0 3 0 0 0 0 0 0 Part I, Line 2: ARMI's monitoring level is dependent on a risk assessment, which is completed on all subawards. Based on this assessment, ARMI performed procedures that included, but were not limited to, the following: o development of a written Statement of Work o periodic conference calls to review progress related to the Statement of Work o review of all deliverables prior to approval of invoices Part III Accounting Method: 1 Advanced Solutions Inc 1901 Nelson Miller Pkwy Louisville KY 40223 462396901 663432 0 See Part IV Applied Biosensors 2500 S State St D224 Salt Lake City UT 84115 462551284 176723 0 Subaward pursuant to our Technology Investment Agreement with the Government Arizona State University Sponsored Projects PO Box 876011 Tempe AZ 852876011 943360412 501(c)(3) 215188 0 Subaward pursuant to our Technology Investment Agreement with the Government Asymmetrex 39 Sheridan Street Boston MA 02130 464401074 14621 0 Subaward pursuant to our Technology Investment Agreement with the Government Axogen Corp 13631 Progress Blvd Ste 400 Alachua FL 32615 411301878 57893 0 Subaward pursuant to our Technology Investment Agreement with the Government Biogen MA Inc 225 Binney St Cambridge MA 02142 330112644 89610 0 Subaward pursuant to our Technology Investment Agreement with the Government Blood Cell Storage Inc 4203 23rd Ave W Seattle WA 981991210 251813861 57643 0 Subaward pursuant to our Technology Investment Agreement with the Government Brown Univerisity Box 1997 69 Brown St 2nd Floor Providence RI 02912 050258809 501(c)(3) 63629 0 Subaward pursuant to our Technology Investment Agreement with the Government ChromoLogic LLC 1225 S Shamrock Ave Monrovia CA 91016 203048938 15637 0 Subaward pursuant to our Technology Investment Agreement with the Government Cornell University - Biomedical Eng PO Box 22 Ithaca NY 148510022 150532082 501(c)(3) 132438 0 Subaward pursuant to our Technology Investment Agreement with the Government Dartmouth College 11 Rope Ferry Rd 6210 Hanover NH 037551404 020222111 501(c)(3) 211116 0 Subaward pursuant to our Technology Investment Agreement with the Government DEKA Integrated Solutions Corp 340 Commercial St Manchester Manchester NH 03101 205085384 224911 0 Subaward pursuant to our Technology Investment Agreement with the Government Epibone 95 Greene Street 3rd Floor Jersey City NJ 07302 800952869 176564 0 See Part IV Georgia Tech Research Corp PO Box 100117 Atlanta GA 30384 586002023 501(c)(3) 141509 0 Subaward pursuant to our Technology Investment Agreement with the Government Girl Scouts of the Green and White Mnts 1 Commerce Dr Bedford NH 031106835 020243160 501(c)(3) 11800 0 Subaward pursuant to our Technology Investment Agreement with the Government INCELL 12734 Cimarron Path San Antonio TX 78249 742699466 94001 0 Subaward pursuant to our Technology Investment Agreement with the Government Massachusetts Institute of Tech 77 Massachusetts Ave Cambridge MA 02139 042103594 501(c)(3) 32885 0 Subaward pursuant to our Technology Investment Agreement with the Government MxD USA 1415 North Cherry Ave Attn Finance Chicago IL 60642 800926174 501(c)(3) 872244 0 BioFabUSA CARES Act Funded Program (DoD-Directed) Neurite 4310 Lane Parke Court Birmingham AL 35223 850506853 26024 0 BioFabUSA CARES Act Funded Program (DoD-Directed) Organamet Bio 430 S Decatur Ave Montgomery AL 36104 872069268 489766 0 Subaward pursuant to our Technology Investment Agreement with the Government Pluristyx 3000 Western Ave Seattle WA 98121 825381269 643723 0 See Part IV RoosterBio 5295 Westview Dr Suite 275 Federick MD 21703 460637361 42695 0 Subaward pursuant to our Technology Investment Agreement with the Government Rutgers University 33 Knightsbridge Rd Piscataway NJ 08854 226001086 171757 0 Subaward pursuant to our Technology Investment Agreement with the Government SEE Science Center Inc 200 Bedford St Manchester NH 03101 274204522 501(c)(3) 18323 0 Subaward pursuant to our Technology Investment Agreement with the Government Sentien Biotechnologies 99 Hayden Ave Bldg E Ste 140 Lexington MA 02421 263782670 10950 0 Subaward pursuant to our Technology Investment Agreement with the Government Southwest Research Institute 6220 Culebra Rd Bldg 160 San Antonio TX 782385166 741070544 501(c)(3) 152101 0 Subaward pursuant to our Technology Investment Agreement with the Government Standards Coordinating Body 100 Bureau Drive MS 8543 Bldg 224 Room A105 Gaithersburg MD 20899 020845002 501(c)(3) 68720 0 Subaward pursuant to our Technology Investment Agreement with the Government Stratatech Corp Mallinckrodt Pharm 675 McDonnell Blvd Hazelwood MO 63042 392025292 83644 0 Subaward pursuant to our Technology Investment Agreement with the Government Sudhin Biopharma Co 685 E Heartstrong Street Superior CO 80027 464990723 150341 0 Subaward pursuant to our Technology Investment Agreement with the Government Terasaki Institute for Biomedical Innovat ATTN Finance 1018 Westwood Blvd Los Angeles CA 900242903 954249502 316224 0 Subaward pursuant to our Technology Investment Agreement with the Government Texas A&M Engineering Experiment Station 400 Harvey Mitchell Pkwy Ste 300 College Station TX 778454375 741974733 13451 0 Subaward pursuant to our Technology Investment Agreement with the Government Trailhead Biosystems Inc 23215 Commerce Park Beachwood OH 44122 474034546 115177 0 See Part IV University of Florida PO BOX 931297 Atlanta GA 311931297 596002052 501(c)(3) 378792 0 Subaward pursuant to our Technology Investment Agreement with the Government University of New Hampshire 51 College Road Room 109 Durham NH 038243585 026000937 501(c)(3) 77554 0 See Part IV University of Notre Dame (ND) 836a Grace Hall Notre Dame IN 46556 350868188 501(c)(3) 74782 0 Subaward pursuant to our Technology Investment Agreement with the Government University of Virginia PO Box 400195 Attn Office of Sponsored Prgms Charlottesville VA 229044195 546001796 501(c)(3) 155369 0 Subaward pursuant to our Technology Investment Agreement with the Government Washington University 7425 Forsyth St St Louis MO 63105 430653611 501(c)(3) 497249 0 Subaward pursuant to our grant with a private foundation WPI 100 Institute Rd Worcester MA 01609 042121659 501(c)(3) 63843 0 Subaward pursuant to our Technology Investment Agreement with the Government X-Therma 2600 Hilltop Dr San Pablo CA 94806 472474292 632120 0 Subaward pursuant to our Technology Investment Agreement with the Government DEKA Research & Development Corp 340 Commercial St Manchester Manchester NH 03101 020361515 254829 0 NextFab Bilateral Health Tech Hub Program (HHS-Directed) The General Hospital Corporation dba Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(c)(3) 308773 0 NextFab Bilateral Health Tech Hub Program (HHS-Directed) DEKA Integrated Solutions Corp 340 Commercial St Manchester Manchester NH 03101 205085384 4163867 0 BiofabUSA CARES Act Funded Program (DOD-Directed) 18 23 Part I, Line 2: ARMI's monitoring level is dependent on a risk assessment, which is completed on all subawards. Based on this assessment, ARMI performed procedures that included, but were not limited to, the following: o development of a written Statement of Work o periodic conference calls to review progress related to the Statement of Work o review of all deliverables prior to approval of invoices Part II, line 1, Column (h): Name of Organization or Government: Advanced Solutions, Inc. (h) Purpose of Grant or Assistance: Subaward pursuant to our Technology Investment Agreement with the Government and our grant with a private foundation Name of Organization or Government: Epibone (h) Purpose of Grant or Assistance: Subaward pursuant to our Technology Investment Agreement with the Government and BioFabUSA CARES Act Funded Program (DoD-Directed) Name of Organization or Government: Pluristyx (h) Purpose of Grant or Assistance: Subaward pursuant to our Technology Investment Agreement with the Government and BioFabUSA CARES Act Funded Program (DoD-Directed) Name of Organization or Government: Trailhead Biosystems Inc. (h) Purpose of Grant or Assistance: Subaward pursuant to our Technology Investment Agreement with the Government and BioFabUSA CARES Act Funded Program (DoD-Directed) Name of Organization or Government: University of New Hampshire (h) Purpose of Grant or Assistance: Subaward pursuant to our Technology Investment Agreement with the Government and U.S. Airforce funded subaward 0 0 0 Edward Gordon Chief Operating Officer - BioFab 192727 0 0 0 0 0 4308 0 31229 0 228264 0 0 0 Richard McFarland Chief Regulatory Officer 195289 0 0 0 0 0 8002 0 18261 0 221552 0 0 0 Julie Lenzer Chief Innovation Officer 178100 0 0 0 0 0 3385 0 12148 0 193633 0 0 0 Kelly Morbey Director of Regulatory Affairs &QA 155000 0 0 0 0 0 6400 0 5560 0 166960 0 0 0 Jeremiah Wille Sr Regulatory Affairs Specialist 160000 0 0 0 0 0 0 0 594 0 160594 0 0 0 See Part V See Part V 224911 Subaward See Part V See Part V See Part V 254829 Subaward See Part V See Part V See Part V 4163867 Subaward See Part V 1890 Associates LLC See Part V 131754 Rent paid 0 1881 Associates LLC See Part V 188436 Rent paid 0 Five Forty N Assoc LLC See Part V 469858 Rent paid 0 Sch L, Part III, Grants or Assistance Benefiting Interested Persons: (a) Name of Person: DEKA Integrated Solutions Corp(b) Relationship Between Interested Person and Organization: Owned more than 35% by Executive Director, Dean Kamen(c) Amount of Grant: $224,911(d) Type of Assistance: Subaward(e) Purpose of Assistance: Subaward issued pursuant to a federal Technology Investment Agreement following a Member-driven, federally-approved governance process with federal veto authority.(a) Name of Person: DEKA Integrated Solutions Corp(b) Relationship Between Interested Person and Organization: Owned more than 35% by Executive Director, Dean Kamen(c) Amount of Grant: $4,163,867(d) Type of Assistance: Subaward(e) Purpose of Assistance: Subaward issued pursuant to a DoD-directed CARES Act program. Program directly selected by DoD.(a) Name of Person: DEKA Research & Development Corp(b) Relationship Between Interested Person and Organization: Owned more than 35% by Executive Director, Dean Kamen(c) Amount of Grant: $254,829(d) Type of Assistance: Subaward(e) Purpose of Assistance: Subaward issued pursuant to a grant with the U.S. Department of Health and Human Services (HHS). Acts as a project management resource and contracting vehicle for projects determined by HHS. Sch L, Part IV, Business Transactions Involving Interested Persons: (a) Name of Person: 1890 Associates, LLC(b) Relationship Between Interested Person and Organization:Owned more than 35% by Executive Director, Dean Kamen(c) Amount of Transaction: $131,754(d) Rent Paid. ARMI follows a process to ensure rent paid is at or below market rate. (a) Name of Person: 1881 Associates, LLC(b) Relationship Between Interested Person and Organization:Owned more than 35% by Executive Director, Dean Kamen(c) Amount of Transaction: $188,436(d) Rent Paid. ARMI follows a process to ensure rent paid is at or below market rate. (a) Name of Person: Five-Forty North Associates, LLC(b) Relationship Between Interested Person and Organization:Owned more than 35% by Executive Director, Dean Kamen(c) Amount of Transaction: $469,858(d) Rent Paid. ARMI follows a process to ensure rent paid is at or below market rate. X Equipment 5 183408 FMV 0 1 0 Form 990, Explanation of Changes to Amended Return: The 2022 Form 990 is being amended for thoroughness and consistency. 1. Schedule L is amended to provide additional detail in Part V. 2. Part VI, Line 2 of Schedule O is updated. Form 990, Part VI, Section A, line 2 James Scott and Brendan Duffy are employees of DEKA, a company owned by Dean Kamen. Maureen Toohey is a member of the Toohey Law Group. The executive director Dean Kamen and board member Martine Rothblatt are directors at Beta Technologies. Form 990, Part VI, Section A, line 6 ARMI is a membership based organization consisting of organizations with interests and/or experience with regenerative medicine and manufacturing in the United States. Form 990, Part VI, Section B, line 11b Key members of management review and comment on the 990 and it is distributed to all board members prior to filing with the Internal Revenue Service. Form 990, Part VI, Section B, line 12c The conflict of interest policy is included on ARMI's internal server, and is posted online on its member portal. Any new employees or officers are provided a copy of this when joining ARMI. Any conflicts are to be reported to the Executive Director or ARMI legal counsel. Form 990, Part VI, Section C, line 19 Upon Request Form 990, Part VII, Section A: As part of its startup activities, per its proposal to the government, the Organization (ARMI) does not pay compensation to some of its officers. Instead, these officers are compensated by member organization DEKA, an unrelated third party, through a government cost share agreement between ARMI and DEKA. DEKA does not treat these compensation payments as a charitable contribution to ARMI; therefore, the compensation is not required to be shown on Part VII, Section A, Line 1a. ARMI Bioindustries Corp 500 Commercial Street Manchester NH 03101 850883563 Biotech Manufacturing and Development Services NH Advanced Regenerative Manufacturing Institute Inc C 312973 307645 1.00000 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 ARMI Bioindutries Corp Q 191903 FMV